Stifel Maintains Hold on TransMedics Group, Raises Price Target to $80

Benzinga · 1d ago
Stifel analyst Tom Stephan maintains TransMedics Group (NASDAQ:TMDX) with a Hold and raises the price target from $70 to $80.